Generative AI: The Next Frontier for Health Care Operations
About 25% of biopharma firms and 10% of medtech players already report tangible business value from AI, including cost reductions and revenue increases of at least 5%. These early adopters are also seeing measurable improvements in speed, compliance, and agility. In contrast, nearly 60% of manufacturers remain cautious, with no clear GenAI strategy or at best, a wait-and-see stance.
Beyond the Buzz: A Pragmatic Executive Blueprint for Scaling Generative Artificial Intelligence
Generative artificial intelligence is no longer a concept restricted to research labs or niche innovation teams. It has arrived in the workplace through intuitive interfaces and real-time utility.
Customer Experience at a Crossroads: Why Leaders must move beyond transactions to build relationships at scale
Those who move swiftly and strategically will set the pace. The rest risk becoming irrelevant. The future of CX is not about perfecting transactions. It is about creating authentic, scalable relationships that grow customer value and loyalty.
India’s GCC Evolution: The Shift from Cost Hubs to Strategic Growth Engines
India’s GCC market is projected to surpass $100 billion by 2030. GCCs are no longer just cost centers; they are becoming direct revenue contributors by powering sales enablement and go-to-market execution.